Jeffrey Taub is an Oncology physician affiliated with Wayne State University. OpenAlex indexes 318 publications with 10,048 citations (h-index 54); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Childrens Hospital Of Michigan
3901 Beaubien Blvd - Cardiology
Detroit, MI 48201
Telephone
313-745-5835Registry record last updated 11 Sept 2025.
Clinical trials
- Studying DNA in Samples From Younger Patients With Down Syndrome and Acute Myeloid Leukemia Treated on COG-AAML0431 Clinical Trial
Sponsor: Children's Oncology Group
- Low-Dose Cytarabine in Treating Infants With Down Syndrome and Transient Myeloproliferative Disorder
Sponsor: Children's Oncology Group
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Hologic Sales and Service, LLCProgram year20251 payment
- JAZZ PHARMACEUTICALS INC.Program year20251 payment
- Alexion Pharmaceuticals, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
4 NIH research awards on record, funded 2001–2025 per NIH RePORTER. The latest:
- Enhancing treatments for myeloid leukemia associated with Down syndrome
Wayne State University
FY2025$314,126R01CA290480 - Enhancing treatments for myeloid leukemia associated with Down syndrome
Wayne State University
FY2024$306,623R01CA290480
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Targeting multiple signaling pathways: the new approach to acute myeloid leukemia therapy
Signal Transduction and Targeted Therapy
2020 - Inhibition of CDK9 by voruciclib synergistically enhances cell death induced by the Bcl-2 selective inhibitor venetoclax in preclinical models of acute myeloid leukemia
Signal Transduction and Targeted Therapy
2020 - A delicate balance – The BCL-2 family and its role in apoptosis, oncogenesis, and cancer therapeutics
Biochemical Pharmacology
2019
Similar KOLs
Other experts from the same institution or the same specialty.
Sonia Hassan, MD
Wayne State University
Tinnakorn Chaiworapongsa, MD
Wayne State University
Robert Sokol, MD
Wayne State University
Robert Lisak, MD
Wayne State University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”